aTYR PHARMA INC — Revenue by Fiscal Year
7 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/4d43f5b7-ddba-4148-a256-1b01cd3424c4/serie/revenue
| Fiscal year | Revenue | Period | Evidence |
|---|---|---|---|
| FY 2025 | $190.0k | 2025-01-01 – 2025-12-31 | evidence 0001339970-26-000008 |
| FY 2024 | $235.0k | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-038888 |
| FY 2023 | $353.0k | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-031584 |
| FY 2022 | $10.4M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-007873 |
| FY 2021 | $0 | 2021-01-01 – 2021-12-31 | evidence 0000950170-24-031584 |
| FY 2020 | $10.5M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-014940 |
| FY 2019 | $422.0k | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-013208 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).